Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Struggling to keep your mid-month budget on track? Learn practical steps to identify overspending, reallocate funds, and implement quick tweaks that stabilize your finances.
23,349 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Investors are watching Nomad Foods navigate a tough year. While the stock has fallen, there are hidden strengths and ...
BTBT's Q4 2025 earnings shed light on mining efficiency, energy spend, and bitcoin price risks. This guide breaks dow...
A stronger-than-expected May jobs report masks deeper tensions. Three warnings from analysts lay out the hidden risks...
A new Fed chair can ripple through markets, but panic isn’t the right play. This article breaks down why chairman kev...
Markets are watching the Fed's next move as rate hikes loom. This guide explains how the pattern of interest rates so...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...
Ford shows a weakness in its truck lineup, and GM may push harder to capture share in the high-margin segment. This a...
Two very different players dominate the modern financial scene: Ally Financial builds on auto lending with a growing ...
In volatile markets, investors seek safety. This guide compares gold, silver, bitcoin, and dividend stocks as safe ha...
A growing glut inventory way—how should savvy investors respond when supply rises and loan terms shift? This guide br...
Sea Ltd reports a sharp rise in 2025 earnings driven by fintech growth and new markets, but worries over profitabilit...